ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call Transcript September 14, 2023 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $0.11 EPS, expectations were $0.17. Operator: Good morning, ladies and gentlemen. Thank you for joining us today for IPA’s Earnings Call covering the First Quarter of Fiscal Year 2024. I am Julianne, and […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,France ,Boston ,Massachusetts ,United States ,Canada ,Canadian ,Janssen Biotherapeutics ,Robert Wasserman ,Ramakanth Swayampakula ,Ingalls Snyder ,Ilse Roodink ,Swayampakula Ramakanth ,Chris Buyse ,Dirk Witters ,Springer Bio ,Brad Mcconn ,Barry Duplantis ,Barry Springer ,Pressmaster Shutterstock ,Johnson ,Group In Corporate ,Most Admired Companies ,Holdingsbv Cash ,Development Presentation ,Hyloris Pharmaceuticals ,Nasdaq ,Jennifer Bath ,Immunoprecise Antibodies ,Springer Bio Tech ,Vice President ,Janssen Strategy ,Conanti Consult ,Investment Banking ,Chief Scientific ,Chief Financial Officer ,Admired Companies ,Before Jennifer ,Client Relations ,Benchmark Capital ,Will Mchale ,Pa ,Quarter ,